TABLE 1.
Cannabinoid tested | Effect and conclusion | References |
---|---|---|
CBD | Decrease of the amplitudes of miniature end-plate potentials in frog neuromuscular junction | Turkanis and Karler, (1986) |
AEA | Inhibition of α7 nACh receptors with IC50 of 229 nM in Xenopus oocytes | Oz et al. (2003) |
2-AG | Inhibition of α7 nACh receptors with IC50 of 168 nM in Xenopus oocytes | Oz et al. (2004b) |
CP55940 | Inhibited α7-nACh receptors with an IC50 value of 2.7 µM in Xenopus oocytes | Oz et al. (2004b) |
AEA | In the concentration range of 200 nM to 2 μM, reduced the maximal amplitudes and increased the desensitization of human α4β2 nACh receptors expressed in SH-EP1 cells | Spivak et al. (2007) |
Methanandamide | Methanandamide (3 μmol/kg) produced an AM 251-insensitive inhibition of the nicotine-induced tachycardia | Baranowska et al. (2008) |
AEA | Inhibited ACh-induced 86Rb+ effluxes with an IC50 of 0.9 µM in rat thalamic synaptosomes | Butt et al. (2008) |
WIN55,212-2 | Inhibited native nicotinic receptor with an IC50 value about 3 µM in cultured rat trigeminal ganglion neurons | Lu et al. (2011) |
CBD | Inhibits human α7-nACh receptor with an IC50 of 11.3 µM in Xenopus oocytes and rat hippocampal interneurons | Mahgoub et al. (2013) |